Merck & Co.'s oral PCSK9 inhibitor succeeds in dual Phase III trials

firstwordpharma.com/story/5970389

This story appeared on firstwordpharma.com, 2025-06-09 21:04:39.329000.
The Entire Business World on a Single Page. Free to Use →